Daniel Files to Receptors, CCR2
This is a "connection" page, showing publications Daniel Files has written about Receptors, CCR2.
Connection Strength
0.211
-
Files DC, Tacke F, O'Sullivan A, Dorr P, Ferguson WG, Powderly WG. Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19. PLoS Pathog. 2022 Jun; 18(6):e1010547.
Score: 0.211